These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19690034)

  • 21. Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo.
    Tavaré R; McCracken MN; Zettlitz KA; Knowles SM; Salazar FB; Olafsen T; Witte ON; Wu AM
    Proc Natl Acad Sci U S A; 2014 Jan; 111(3):1108-13. PubMed ID: 24390540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-MET immunoPET for non-small cell lung cancer using novel fully human antibody fragments.
    Li K; Tavaré R; Zettlitz KA; Mumenthaler SM; Mallick P; Zhou Y; Marks JD; Wu AM
    Mol Cancer Ther; 2014 Nov; 13(11):2607-17. PubMed ID: 25143449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerenkov Luminescence Imaging as a Modality to Evaluate Antibody-Based PET Radiotracers.
    D'Souza JW; Hensley H; Doss M; Beigarten C; Torgov M; Olafsen T; Yu JQ; Robinson MK
    J Nucl Med; 2017 Jan; 58(1):175-180. PubMed ID: 27539844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted alpha immunotherapy of CD20-positive B-cell lymphoma model: dosimetry estimate of
    Lee CH; Lim I; Woo SK; Kim W; Kim KI; Lee KC; Song K; Lim SM
    Ann Nucl Med; 2021 May; 35(5):639-647. PubMed ID: 33811601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Next-Generation Anti-CD20 Antibodies Labeled with
    Yoon JT; Longtine MS; Marquez-Nostra BV; Wahl RL
    J Nucl Med; 2018 Aug; 59(8):1219-1224. PubMed ID: 29348316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humanized radioiodinated minibody for imaging of prostate stem cell antigen-expressing tumors.
    Leyton JV; Olafsen T; Lepin EJ; Hahm S; Bauer KB; Reiter RE; Wu AM
    Clin Cancer Res; 2008 Nov; 14(22):7488-96. PubMed ID: 19010866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 64Cu-labeled minibody D2101 visualizes CDH17-positive gastric cancer xenografts with short waiting time.
    Fujiwara K; Akiba H; Tsuji AB; Sudo H; Sugyo A; Nagatsu K; Zhang MR; Iwanari H; Kusano-Arai O; Kudo S; Kikuchi C; Tsumoto K; Momose T; Hamakubo T; Higashi T
    Nucl Med Commun; 2020 Jul; 41(7):688-695. PubMed ID: 32371673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro characterization of (177)Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry study.
    Forrer F; Chen J; Fani M; Powell P; Lohri A; Müller-Brand J; Moldenhauer G; Maecke HR
    Eur J Nucl Med Mol Imaging; 2009 Sep; 36(9):1443-52. PubMed ID: 19350237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positron emission tomography of 64Cu-DOTA-Rituximab in a transgenic mouse model expressing human CD20 for clinical translation to image NHL.
    Natarajan A; Gowrishankar G; Nielsen CH; Wang S; Iagaru A; Goris ML; Gambhir SS
    Mol Imaging Biol; 2012 Oct; 14(5):608-16. PubMed ID: 22231277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of an anti-p185(HER2) (scFv-C(H)2-C(H)3)2 fragment following radioiodination using two different residualizing labels: SGMIB and IB-Mal-D-GEEEK.
    Vaidyanathan G; Jestin E; Olafsen T; Wu AM; Zalutsky MR
    Nucl Med Biol; 2009 Aug; 36(6):671-80. PubMed ID: 19647173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of 89Zr-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.
    Jauw YW; Zijlstra JM; de Jong D; Vugts DJ; Zweegman S; Hoekstra OS; van Dongen GA; Huisman MC
    PLoS One; 2017; 12(1):e0169828. PubMed ID: 28060891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD20 antigen imaging with ¹²⁴I-rituximab PET/CT in patients with rheumatoid arthritis.
    Tran L; Huitema AD; van Rijswijk MH; Dinant HJ; Baars JW; Beijnen JH; Vogel WV
    Hum Antibodies; 2011; 20(1-2):29-35. PubMed ID: 21558621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiation Dosimetry Study of [(89)Zr]rituximab Tracer for Clinical Translation of B cell NHL Imaging using Positron Emission Tomography.
    Natarajan A; Gambhir SS
    Mol Imaging Biol; 2015 Aug; 17(4):539-47. PubMed ID: 25500766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and Validation of an Immuno-PET Tracer as a Companion Diagnostic Agent for Antibody-Drug Conjugate Therapy to Target the CA6 Epitope.
    Ilovich O; Natarajan A; Hori S; Sathirachinda A; Kimura R; Srinivasan A; Gebauer M; Kruip J; Focken I; Lange C; Carrez C; Sassoon I; Blanc V; Sarkar SK; Gambhir SS
    Radiology; 2015 Jul; 276(1):191-8. PubMed ID: 25734548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intratumoral but not systemic delivery of CpG oligodeoxynucleotide augments the efficacy of anti-CD20 monoclonal antibody therapy against B cell lymphoma.
    Betting DJ; Yamada RE; Kafi K; Said J; van Rooijen N; Timmerman JM
    J Immunother; 2009; 32(6):622-31. PubMed ID: 19483647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant interleukin-2 significantly augments activity of rituximab in human tumor xenograft models of B-cell non-Hodgkin lymphoma.
    Lopes de Menezes DE; Denis-Mize K; Tang Y; Ye H; Kunich JC; Garrett EN; Peng J; Cousens LS; Gelb AB; Heise C; Wilson SE; Jallal B; Aukerman SL
    J Immunother; 2007 Jan; 30(1):64-74. PubMed ID: 17198084
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.